(Q34365079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

From NAFLD to NASH to cirrhosis-new insights into disease mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Alexander Wree

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Lori Broderick

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hal M Hoffman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

20 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

627-636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.149

7 March 2020

exact match

0 references

cites work

The epidemiology, pathogenesis and histopathology of fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

The epidemiology of nonalcoholic fatty liver disease: a global perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Management of nonalcoholic steatohepatitis: an evidence-based approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

The interaction of hepatic lipid and glucose metabolism in liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Obesity affects the liver - the link between adipocytes and hepatocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

How different is the dietary pattern in non-alcoholic steatohepatitis patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Dietary habits and nutrient intake in non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

A lipidomic analysis of nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Carbohydrate intake and nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Metabolic effects of fructose and the worldwide increase in obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Mechanisms for the acute effect of fructose on postprandial lipemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Does fructose consumption contribute to non-alcoholic fatty liver disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Dietary fructose in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Predicting metabolic syndrome in obese children and adolescents: look, measure and ask.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Immunodeficiency and genetic defects of pattern-recognition receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Pattern recognition receptors and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Liver: An organ with predominant innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Toll-like receptors and adaptor molecules in liver disease: update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Toll-like receptors as targets in chronic liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Metabolic endotoxemia initiates obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Role of TLR9 in hepatic stellate cells and experimental liver fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Tlr2 is critical for diet-induced metabolic syndrome in a murine model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Inflammasomes in liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Microbiota: Dysbiosis driven by inflammasome deficiency exacerbates hepatic steatosis and governs rate of NAFLD progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Intrahepatic natural killer T cell populations are increased in human hepatic steatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Mcl-1 degradation during hepatocyte lipoapoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Apoptosis: the nexus of liver injury and fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Autophagy and cell death.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Autophagy regulates lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Selective degradation of mitochondria by mitophagy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Mitochondrial abnormalities in non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Mechanisms of hepatic fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Necroptosis: biochemical, physiological and pathological aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Pro-inflammatory programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Smad2 and 3 transcription factors control muscle mass in adulthood.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Hepatocyte Death: A Clear and Present Danger

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.149

Autophagy regulates adipose mass and differentiation in mice

31 March 2020

1 reference

12 December 2020

Biological significance of essential fatty acids.

1 reference

12 December 2020

Apoptotic body engulfment by a human stellate cell line is profibrogenic.

1 reference

12 December 2020

Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression

1 reference

12 December 2020

Inflammasome-mediated regulation of hepatic stellate cells

1 reference

12 December 2020

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization

1 reference

12 December 2020

Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms

1 reference

12 December 2020

Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis

1 reference

12 December 2020

10.1038/NRGASTRO.2013.149

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23958599%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference